Immunosuppressive Agents: all 5,940 studies that test it

Page 36 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy Plus Reduced Radiotherapy in Intracranial GerminomaStatus unknownNCT02782754Phase 2
• Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaCompletedNCT02779283Phase 1
• Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive ArthralgiaCompletedNCT02778906Phase 3
• Conmana Combined With Thalidomide to Treat NSCLCStatus unknownNCT02778893Phase 4
• CNS Prophylaxis in Diffuse Large B-cell LymphomaStatus unknownNCT02777736Phase 3
• HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning RegimenStatus unknownNCT02776202Phase 2
• Response-based Treatment of High-risk NeuroblastomaStatus unknownNCT02771743Phase 2
• NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/AdolescentsCompletedNCT02763475Phase 2
• A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and MetforminCompletedNCT02760342Phase 1
• Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus ErythematosisCompletedNCT02756546Phase 1/2
• Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsCompletedNCT02755844Phase 1/2
• Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related BleedingWithdrawnNCT02754960Phase 2
• A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder CancerCompletedNCT02753309Early Phase 1
• Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen PlanusCompletedNCT02744378Phase 2
• Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid ArthritisCompletedNCT02744196Phase 3
• Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy AdultsCompletedNCT02743247Phase 1
• A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast CancerCompletedNCT02742051Phase 2
• Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.CompletedNCT02738918Phase 2
• Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell LymphomaStatus unknownNCT02733380Phase 2
• Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTTerminatedNCT02728700Phase 1
• Protocol for the Treatment of Metastatic Ewing SarcomaCompletedNCT02727387Phase 2
• Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For LymphomaWithdrawnNCT02724904Phase 1/2
• Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven MedulloblastomaActive, not recruitingNCT02724579Phase 2
• Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCCCompletedNCT02724332Phase 1
• Efficacy of Subcutaneous Injection of Etanercept for Moderate and Severe Knee OsteoarthritisStatus unknownNCT02722811Not applicable
• Efficacy of Intra-Articular Injection of Etanercept for Moderate and Severe Knee OsteoarthritisStatus unknownNCT02722772Not applicable
• A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateStatus unknownNCT02722694Phase 3
• Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by MethotrexateStatus unknownNCT02715947Phase 2
• The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic PregnancyCompletedNCT02714998Not applicable
• the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular MalformationCompletedNCT02707484Phase 3
• Allogeneic Stem Cell Transplantation for Children With CMLCompletedNCT02707393Phase 2/3
• Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant RecipientsCompletedNCT02706678Phase 4
• Use of Cyclosporin A for the Treatment of Recurrent MiscarriageStatus unknownNCT02706470Phase 2/3
• Leflunomide for Maintenance of Remission in IgG4 Related DiseaseCompletedNCT02703194Phase 4
• Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)WithdrawnNCT02702960Phase 2
• Cyclosporine Plus Methotrexate or AlemtuzumabTerminatedNCT02701517Phase 2
• Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque PsoriasisStatus unknownNCT02701205Phase 3
• Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy SubjectsCompletedNCT02699710Phase 1
• Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary OriginStatus unknownNCT02695459Phase 2
• A Study to Evaluate the Efficacy and Safety of Mabthera Alone and in Combination With Either Cyclophosphamide or Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT02693210Phase 2
• Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia PatientsStatus unknownNCT02690922Phase 4
• Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid TumorsCompletedNCT02688881Phase 4
• Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic OriginActive, not recruitingNCT02687958Phase 2
• Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in ColitisStatus unknownNCT02687724Phase 4
• Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant RecipientsCompletedNCT02686619Phase 3
• A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing SpondylitisTerminatedNCT02685904Phase 3
• Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/LymphomaStatus unknownNCT02685670Phase 1/2
• Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain TumorsTerminatedNCT02684071Phase 2
• Pharmacokinetics of DMF and the Effects of DMF on Exploratory BiomarkersCompletedNCT02683863Phase 4
• Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant PatientsCompletedNCT02683291Phase 4
• Denosumab as an add-on Neoadjuvant Treatment (GeparX)CompletedNCT02682693Phase 2
• Comparative Effectiveness Trial in the Treatment of Pediatric Plaque MorpheaWithdrawnNCT02680717Phase 1
• Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell DiseaseTerminatedNCT02678143Phase 1
• Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCTCompletedNCT02677181Phase 4
• Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic SyndromeTerminatedNCT02676323Phase 1
• Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MSWithdrawnNCT02675413Phase 4
• To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related StrictureStatus unknownNCT02675153Not applicable
• Conversion to Sirolimus: Effects in Cytomegalovirus Infection RecurrenceStatus unknownNCT02671318Phase 4
• Phase II Study About Combination CHOP-21, Obinutuzumab and Ibrutinib in Untreated Young High Risk DLBCL Patients.TerminatedNCT02670317Phase 2
• Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer PatientsStatus unknownNCT02670109Phase 2
• Allo HSCT Using RIC for Hematological DiseasesCompletedNCT02661035Phase 2
• Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALLStatus unknownNCT02660762Phase 2
• Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling DonorCompletedNCT02660684Phase 4
• Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus ErythematosusCompletedNCT02656082Phase 2
• Comparison Study of Psoriasis Severity Assessment ToolsCompletedNCT02655705Phase 4
• A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsTerminatedNCT02653196Early Phase 1
• Inhibition of Co-Stimulation in Rheumatoid ArthritisStatus unknownNCT02652273Phase 4
• TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsTerminatedNCT02650635Phase 1
• Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT02649764Phase 1
• Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast CancerStatus unknownNCT02649101Phase 2
• Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus NephritisCompletedNCT02645565Phase 4
• Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid ArthritisCompletedNCT02644499Phase 4
• Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm StudyStatus unknownNCT02644044Early Phase 1
• Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell TransplantationStatus unknownNCT02643589Not applicable
• Dose Reduction of Etanercept in Patients With Ankylosing SpondylitisStatus unknownNCT02638896Phase 4
• Genomics-Based Target Therapy for Children With Relapsed or Refractory MalignancyStatus unknownNCT02638428Phase 2
• Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus NephritisCompletedNCT02630628Phase 3
• A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)Status unknownNCT02630368Phase 1/2
• Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic LeukemiaActive, not recruitingNCT02629809Phase 2
• High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous DiseaseActive, not recruitingNCT02629120Phase 1/2
• Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCTTerminatedNCT02627573Phase 2
• CD123 Redirected Autologous T Cells for AMLTerminatedNCT02623582Early Phase 1
• Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast CancersStatus unknownNCT02616848Phase 1
• Corticosteroid Injection Verses High Energy Extracorporeal Shock Wave Therapy for Lateral EpicondylitisStatus unknownNCT02613455Phase 4
• Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast CancerCompletedNCT02613026Phase 3
• Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic ReceptorsCompletedNCT02608606Not applicable
• Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast CancerCompletedNCT02605915Phase 1
• Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal FunctionCompletedNCT02603497Phase 1
• To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)CompletedNCT02601703Phase 3
• Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular EdemaWithdrawnNCT02598869Phase 4
• Does Clinical Response Correlate With Serum Certolizumab Levels?Status unknownNCT02597829Phase 4
• Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade PineoblastomaCompletedNCT02596828Phase 2
• Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell LymphomaWithdrawnNCT02595242Phase 1
• Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast CancerCompletedNCT02593227Phase 2
• Different Dose of Methotrexate for the Treatment of Meningeal CarcinomatosisStatus unknownNCT02590510Phase 4
• A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension PeriodCompletedNCT02587195Phase 3
• Diabetes Islet Preservation Immune TreatmentWithdrawnNCT02586831Phase 1/2
• Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870CompletedNCT02586246Phase 3
• Pharmacokinetics Study in Patients With Impaired Hepatic FunctionCompletedNCT02586194Phase 1
• Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer PatientsCompletedNCT02583828Not applicable

← Immunosuppressive Agents overview